This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Esken Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Esken şirketinin toplam hissedar öz sermayesi £-19.3M ve toplam borcu £274.6M olup, bu da borç-öz sermaye oranını -1420.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £397.6M ve £416.9M dir.

Anahtar bilgiler

-1,420.1%

Borç/özkaynak oranı

UK£274.61m

Borç

Faiz karşılama oranı	n/a
Nakit	UK£19.96m
Eşitlik	-UK£19.34m
Toplam yükümlülükler	UK£416.94m
Toplam varlıklar	UK£397.60m

Son finansal sağlık güncellemeleri

Does Esken (LON:ESKN) Have A Healthy Balance Sheet?

Feb 19

Is Stobart Group (LON:STOB) Using Debt In A Risky Way?

Jan 21

Recent updates

It's Down 39% But Esken Limited (LON:ESKN) Could Be Riskier Than It Looks

Dec 28

Growth Investors: Industry Analysts Just Upgraded Their Esken Limited (LON:ESKN) Revenue Forecasts By 6.4%

Nov 13

Is Stobart Group Limited's (LON:STOB) Shareholder Ownership Skewed Towards Insiders?

Dec 07

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ESKN negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: ESKN şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ESKN negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: ESKN 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: ESKN şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: Serbest nakit akışı her yıl % 15.9 oranında tarihsel oranda büyümeye devam ederse ESKN un bir yıldan az nakit akışı süresi vardır.

This company listing is no longer active

Esken Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Esken Announces Cancellation of Listing its Ordinary Shares on the Official List of the Financial Conduct Authority, Effective 8.00 A.M. on 2 April 2024

Does Esken (LON:ESKN) Have A Healthy Balance Sheet?

Is Stobart Group (LON:STOB) Using Debt In A Risky Way?

Stobart Group Limited Auditor Raises 'Going Concern' Doubt

Recent updates

Esken Announces Cancellation of Listing its Ordinary Shares on the Official List of the Financial Conduct Authority, Effective 8.00 A.M. on 2 April 2024

New major risk - Market cap size

It's Down 39% But Esken Limited (LON:ESKN) Could Be Riskier Than It Looks

New major risk - Share price stability

First half 2024 earnings released: UK£0.059 loss per share (vs UK£0.012 loss in 1H 2023)

New major risk - Negative shareholders equity

Esken Limited to Report First Half, 2024 Results on Nov 29, 2023

Esken Limited in Advanced Discussions with Pioneer Point Partners Regarding A Possible Disposal of the Entire Issued Share Capital of Esken Renewables

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Esken Limited, Annual General Meeting, Aug 30, 2023

Insufficient new directors

Esken Limited Announces Chief Financial Officer Changes

New major risk - Share price stability

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Esken Limited(LSE:ESKN) dropped from FTSE All-Share Index (GBP)

Esken Limited to Report Fiscal Year 2023 Results on Jun 21, 2023

Price target decreased to UK£0.17

Growth Investors: Industry Analysts Just Upgraded Their Esken Limited (LON:ESKN) Revenue Forecasts By 6.4%

First half 2023 earnings released

Esken Limited to Report First Half, 2023 Results on Nov 09, 2022

Price target decreased to UK£0.17

Insufficient new directors

Esken Limited, Annual General Meeting, Jul 13, 2022

Consensus forecasts updated

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Esken Limited to Report Fiscal Year 2022 Results on May 25, 2022

Now 21% undervalued after recent price drop

Price target decreased to UK£0.27

Does Esken (LON:ESKN) Have A Healthy Balance Sheet?

First half 2022 earnings released: UK£0.006 loss per share (vs UK£0.033 loss in 1H 2021)

Esken Limited has completed a Follow-on Equity Offering in the amount of £54.459314 million.

Full year 2021 earnings released: UK£0.27 loss per share (vs UK£0.41 loss in FY 2020)

Ettyl Reportedly Circles Stobart Air

Aviation Executive Reportedly in Talks to Acquire Stobart Air

Did Esken Limited (LON:ESKN) Insiders Buy Up More Shares?

Esken Limited Announces Resignation of Warwick Brady as Chief Executive Officer

Esken Limited Announces Appointment of David Shearer as Executive Chairman

Stobart Group Limited(LSE:STOB) dropped from FTSE 350 Index (GBP)

Is Stobart Group (LON:STOB) Using Debt In A Risky Way?

New 90-day high: UK£0.28

Stobart Group's (LON:STOB) Stock Price Has Reduced 91% In The Past Three Years

Is Stobart Group Limited's (LON:STOB) Shareholder Ownership Skewed Towards Insiders?

Stobart Group Still Remains in Talks to Sell Stobart Air

Stobart Group Limited Appoints David Blackwood as Senior Independent Director

Price target raised to UK£1.52

Stobart Air Sale Talks Up in the Air After Tender Move

Price target lowered to UK£0.94

Stobart Group Confirms Talks to Sell Stobart Air

New 90-day low - UK£0.23

New 90-day low - UK£0.24

Price target raised to UK£1.14

New 90-day low - UK£0.24

Stobart Group Limited (LSE:STOB) entered into an agreement to acquire 78.75% stake in Propius Holdings Limited and Stobart Air Unlimited Company from Connect Airways Limited for £8.55 million.

Stobart Group Limited Auditor Raises 'Going Concern' Doubt

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin